Bridgefront Capital, LLC Bausch Health Companies Inc. Transaction History

Bridgefront Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$7.69 - $9.71 $95,832 - $121,006	12,462 New	12,462 $102,000
Q3 2021 Nov 12, 2021	SELL	$25.04 - $30.06 $181,264 - $217,604	-7,239 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$27.43 - $32.7 $303,458 - $361,760	-11,063 Reduced 60.45%	7,239 $212,000
Q1 2021 May 17, 2021	BUY	$21.37 - $34.38 $34,598 - $55,661	1,619 Added 9.7%	18,302 $581,000
Q4 2020 Feb 12, 2021	BUY	$15.31 - $21.12 $255,416 - $352,344	16,683 New	16,683 $347,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgefront Capital, LLC with notifications on news.